/PRNewswire/ The "Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product , By Application, By End-Use, By Region, Segment.
a >5-fold increase. The addition of motixafortide to G-CSF also allowed 88.3% of patients to undergo transplantation after only one apheresis session, compared to 10.8% in the G-CSF arm - an. | March 16, 2022
Covid 19 coronavirus: Kiwi tech could offer low-cost immunity test
22 Feb, 2021 01:41 AM
4 minutes to read
Kiwi-developed technology - using synthetic paint to coat the outside of our red blood cells - could offer a low-cost way to test for Covid-19 immunity. Photo / USCDC
Kiwi-developed technology - using synthetic paint to coat the outside of our red blood cells - could offer a low-cost way to test for Covid-19 immunity. Photo / USCDC
Kiwi-developed technology - using synthetic paint to coat the outside of our red blood cells - could offer a low-cost way to test for Covid-19 immunity. The test, carried out in a just-published,